Cargando…

Time to improve transparency at Health Canada’s Pest Management Regulatory Agency

Detalles Bibliográficos
Autores principales:	Gagnon, Marc-André, Bacon, Marie-Hélène
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681681/ https://www.ncbi.nlm.nih.gov/pubmed/38011929 http://dx.doi.org/10.1503/cmaj.231089

Ejemplares similares

Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada"
por: Gagnon, Marc-André
Publicado: (2020)

Poisoning Regulation, Research, Health, and the Environment: The Glyphosate-Based Herbicides Case in Canada
por: Bacon, Marie-Hélène, et al.
Publicado: (2023)

Revolving doors and conflicts of interest in health regulatory agencies in Brazil
por: Scheffer, Mário C, et al.
Publicado: (2020)

Decisions by regulatory agencies: are they evidence-based?
por: Furberg, Curt D
Publicado: (2007)

Access to regulatory data from the European Medicines Agency: the times they are a-changing
por: Wieseler, Beate, et al.
Publicado: (2012)

Time for a regulatory framework for pediatric medications in Canada
por: Gilpin, Andrea, et al.
Publicado: (2022)

Sustainable Pest Management for Health and Well-Being
por: Liu, Qiyong
Publicado: (2020)

Establishment of the African Medicines Agency: progress, challenges and regulatory readiness
por: Ncube, Bakani Mark, et al.
Publicado: (2021)

Informed consent: time for more transparency
por: Yazici, Yusuf, et al.
Publicado: (2010)

New Health Technologies: A UK Perspective: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Parvizi, Nassim, et al.
Publicado: (2017)

The Role of Regulatory Sciences from the Perspective of the Cuban Medicines Regulatory Agency: The Impact of COVID-19 in Promoting Innovation, Cooperation and Scientific Thinking
por: Romeu, Belkis, et al.
Publicado: (2021)

The Bright Elusive Butterfly of Value in Health Technology Development: Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Greenhalgh, Trisha, et al.
Publicado: (2017)

The Conceptualization of Value in the Value Proposition of New Health Technologies : Comment on "Providing Value to New Health Technology: The Early Contribution of Entrepreneurs, Investors, and Regulatory Agencies"
por: Buttigieg, Sandra C., et al.
Publicado: (2017)

Biomonitoring Studies Should Be Used by Regulatory Agencies to Assess Human Exposure Levels and Safety of Bisphenol A
por: Vandenberg, Laura N., et al.
Publicado: (2010)

Regulatory agencies have a role to play in maintaining consumer confidence in vaccine safety for pregnant women
por: Giles, Michelle L., et al.
Publicado: (2020)

Public trust on regulatory decisions: The European Medicines Agency and the AstraZeneca COVID-19 vaccine label
por: Dal-Ré, Rafael, et al.
Publicado: (2021)

Moral Lacunae in the Management of Dual Agency Dilemmas: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Lipworth, Wendy
Publicado: (2022)

It’s plain and simple: transparency is good for science and in the public interest
por: Denegri, Simon, et al.
Publicado: (2013)

Harnessing “little mighty” cockroaches: Pest management and beneficial utilization
por: Ren, Chonghua, et al.
Publicado: (2023)

Infusing Equity Into Organizational Culture at Governmental Public Health Agencies
por: Travis, Alexis
Publicado: (2023)

An Appetite for Modernizing the Regulatory Framework for Protein Content Claims in Canada
por: Marinangeli, Christopher P. F., et al.
Publicado: (2017)

Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research
por: Moher, David, et al.
Publicado: (2008)

Pharmacovigilance and the Italian Medicines Agency
por: Pimpinella, Giuseppe, et al.
Publicado: (2013)

Aiming for agency and authenticity in assessment
por: Harrison, Christopher
Publicado: (2018)

Reporting guidelines for realist evaluations seek to improve clarity and transparency
por: Welch, Vivian A., et al.
Publicado: (2016)

HTA Agencies Need Evidence-Informed Deliberative Processes Comment on "Use of Evidence-Informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Schlander, Michael
Publicado: (2020)

Varieties of transparency: exploring agency within AI systems
por: Andrada, Gloria, et al.
Publicado: (2022)

The importance of power and agency in a universal health coverage agenda for adolescent girls
por: Ricker, Chelsea L., et al.
Publicado: (2020)

Advancing health equity‐Agency for Healthcare Research and Quality research and action agenda
por: Mistry, Kamila B., et al.
Publicado: (2023)

Between persuasion and compulsion: The case of COVID-19 vaccination in Canada
por: Dubé, Eve, et al.
Publicado: (2022)

Dual Goals, Dual Agency: The Perils of Measurement and Control: Comment on "Dual Agency in Hospitals: What Strategies Do Managers and Physicians Apply to Reconcile Dilemmas Between Clinical and Economic Considerations?"
por: Greve, Henrich R.
Publicado: (2022)

Improving post-tuberculosis care in Canada
por: Romanowski, Kamila, et al.
Publicado: (2022)

Improving regulatory capacity to manage risks associated with trade agreements
por: Walls, Helen L, et al.
Publicado: (2015)

Deliberative Processes by Health Technology Assessment Agencies: A Reflection on Legitimacy, Values and Patient and Public Involvement Comment on "Use of Evidence-informed Deliberative Processes by Health Technology Assessment Agencies Around the Globe"
por: Goetghebeur, Mireille, et al.
Publicado: (2020)

Models of professional regulation: institutionalizing an agency relationship
por: Tuohy, Carolyn Hughes
Publicado: (2013)

A bacteriophage journey at the European Medicines Agency
por: Debarbieux, Laurent, et al.
Publicado: (2015)

Establishing Appropriate Agency Relationships for Providers in China
por: Liu, Yu, et al.
Publicado: (2019)

Reflections on Choice and Agency in Context: a Reply
por: Piquero, Alex R.
Publicado: (2021)

Women and girls’ health agency: Operationalizing the “Can-Act-Resist” of the women's empowerment process
por: Raj, Anita
Publicado: (2020)

Science, Policy, and the Transparency of Values
por: Elliott, Kevin C., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_m8oojb392t897ch00mqe8bh2tn